{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:03:28Z","timestamp":1789603408432,"version":"build-2803163510"},"reference-count":67,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22305167"],"award-info":[{"award-number":["22305167"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U23A20516"],"award-info":[{"award-number":["U23A20516"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52303191"],"award-info":[{"award-number":["52303191"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204505"],"award-info":[{"award-number":["82204505"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2022YFC3502000"],"award-info":[{"award-number":["2022YFC3502000"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.apsb.2026.06.044","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:42:11Z","timestamp":1782517331000},"page":"6253-6273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Self-assembled supramolecular nanoparticles of \u03b1-mangostin for targeted STING activation and enhanced tumor immunotherapy"],"prefix":"10.1016","volume":"16","author":[{"given":"Jiaqian","family":"Miao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinxuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianli","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhui","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongping","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9670-4349","authenticated-orcid":false,"given":"Guangbo","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2026.06.044_bib1","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/s43018-022-00468-w","article-title":"The cGAS-STING pathway and cancer","volume":"3","author":"Samson","year":"2022","journal-title":"Nat Cancer"},{"key":"10.1016\/j.apsb.2026.06.044_bib2","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/s41586-023-05880-5","article-title":"STING inhibits the reactivation of dormant metastasis in lung adenocarcinoma","volume":"616","author":"Hu","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.06.044_bib3","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41581-022-00589-6","article-title":"Role of the cGAS-STING pathway in systemic and organ-specific diseases","volume":"18","author":"Skopelja-Gardner","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.apsb.2026.06.044_bib4","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s41388-019-1108-8","article-title":"The cGAS-STING pathway is a therapeutic target in a preclinical model of hepatocellular carcinoma","volume":"39","author":"Thomsen","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.apsb.2026.06.044_bib5","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/s41590-024-01872-3","article-title":"The balance of STING signaling orchestrates immunity in cancer","volume":"25","author":"Lanng","year":"2024","journal-title":"Nat Immunol"},{"key":"10.1016\/j.apsb.2026.06.044_bib6","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature07317","article-title":"STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling","volume":"455","author":"Ishikawa","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.06.044_bib7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41577-024-01112-7","article-title":"Regulation of cGAS-STING signalling and its diversity of cellular outcomes","volume":"25","author":"Zhang","year":"2025","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2026.06.044_bib8","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41580-020-0244-x","article-title":"Molecular mechanisms and cellular functions of cGAS-STING signalling","volume":"21","author":"Hopfner","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.apsb.2026.06.044_bib9","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.immuni.2021.10.020","article-title":"Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity","volume":"55","author":"Duong","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2026.06.044_bib10","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.celrep.2019.09.089","article-title":"Magnitude of therapeutic STING activation determines CD8+ T cell-mediated anti-tumor immunity","volume":"29","author":"Sivick","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2026.06.044_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002852","article-title":"STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation","volume":"9","author":"Nakamura","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.apsb.2026.06.044_bib12","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1038\/s41467-022-30568-1","article-title":"STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer","volume":"13","author":"Wang","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.06.044_bib13","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1078-0432.CCR-21-1963","article-title":"Phase I dose-escalation trial of MIW815 (ADU-S100), an intratumoral STING agonist, in patients with advanced\/metastatic solid tumors or lymphomas","volume":"28","author":"Meric-Bernstam","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2026.06.044_bib14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1158\/1078-0432.CCR-22-2235","article-title":"Combination of the STING agonist MIW815 (ADU-S100) and PD-1 inhibitor spartalizumab in advanced\/metastatic solid tumors or lymphomas","volume":"29","author":"Meric-Bernstam","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2026.06.044_bib15","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/annonc\/mdy424.015","article-title":"Preliminary results of the first-in-human study of MK-1454, an agonist of stimulator of interferon genes (STING), as monotherapy or in combination with pembrolizumab (pembro) in patients with advanced solid tumors or lymphomas","volume":"29","author":"Harrington","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.apsb.2026.06.044_bib16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11912-023-01361-0","article-title":"The development of STING agonists and emerging results as a cancer immunotherapy","volume":"25","author":"Hines","year":"2023","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.apsb.2026.06.044_bib17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2147\/IJN.S503780","article-title":"Novel modifications and delivery modes of cyclic dinucleotides for STING activation in cancer treatment","volume":"20","author":"Lu","year":"2025","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.apsb.2026.06.044_bib18","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.tips.2022.08.006","article-title":"Nanodelivery of cGAS-STING activators for tumor immunotherapy","volume":"43","author":"Guo","year":"2022","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.apsb.2026.06.044_bib19","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.1021\/acs.chemrev.1c00750","article-title":"Chemical and biomolecular strategies for STING pathway activation in cancer immunotherapy","volume":"122","author":"Garland","year":"2022","journal-title":"Chem Rev"},{"key":"10.1016\/j.apsb.2026.06.044_bib20","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1021\/acs.accounts.3c00394","article-title":"Engineering and delivery of cGAS-STING immunomodulators for immunotherapy","volume":"56","author":"Zhou","year":"2023","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.apsb.2026.06.044_bib21","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41392-022-01252-z","article-title":"Multifaceted functions of STING in human health and disease","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.apsb.2026.06.044_bib22","article-title":"Mn and Zn-doped multivariate metal-organic framework as metalloimmunological adjuvant","volume":"8","author":"Howlett","year":"2024","journal-title":"Adv Healthcare Mater"},{"key":"10.1016\/j.apsb.2026.06.044_bib23","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1021\/acscentsci.4c00579","article-title":"STING-activating polymer-drug conjugates for cancer immunotherapy","volume":"10","author":"Sheehy","year":"2024","journal-title":"ACS Cent Sci"},{"key":"10.1016\/j.apsb.2026.06.044_bib24","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/s41565-023-01447-7","article-title":"Investigation of enhanced antitumour potency of STING agonist after conjugation to polymer nanoparticles","volume":"18","author":"Dosta","year":"2023","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2026.06.044_bib25","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1021\/acsnano.4c10202","article-title":"A pH-responsive and guanidinium-rich nanoadjuvant efficiently delivers STING agonist for cancer immunotherapy","volume":"19","author":"Lu","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2026.06.044_bib26","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1038\/s41467-023-40312-y","article-title":"Chemically programmed STING-activating nano-liposomal vesicles improve anticancer immunity","volume":"14","author":"Chen","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.06.044_bib27","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41467-024-55751-4","article-title":"Inhalable nanovesicles loaded with a STING agonist enhance CAR-T cell activity against solid tumors in the lung","volume":"16","author":"Zhu","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.06.044_bib28","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jconrel.2024.12.034","article-title":"Engineered virus-mimicking nanovaccine with lymph node-tumor dual-targeting and STING-activating capacity for robust cancer immunotherapy","volume":"378","author":"Wang","year":"2025","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2026.06.044_bib29","article-title":"Multifunctional mesoporous polydopamine-based systematic delivery of STING agonist for enhanced synergistic photothermal-immunotherapy","volume":"34","author":"Zeng","year":"2024","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.apsb.2026.06.044_bib30","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.apsb.2024.06.004","article-title":"Intravenous delivery of STING agonists using acid-sensitive polycationic polymer-modified lipid nanoparticles for enhanced tumor immunotherapy","volume":"15","author":"He","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.06.044_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2024.109856","article-title":"Tumor-responsive covalent organic polymeric nanoparticles enhancing STING activation for cancer immunotherapy","volume":"36","author":"Liang","year":"2025","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.apsb.2026.06.044_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2024.110437","article-title":"Amplifying STING activation and immunogenic cell death by metal-polyphenol coordinated nanomedicines for enhanced cancer immunotherapy","volume":"36","author":"Cai","year":"2025","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.apsb.2026.06.044_bib33","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1016\/j.apsb.2024.04.028","article-title":"Inhalable nanoparticles with enhanced cuproptosis and cGAS-STING activation for synergistic lung metastasis immunotherapy","volume":"14","author":"Yan","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.06.044_bib34","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1039\/D4BM01153H","article-title":"Recent advances in carrier-free natural small molecule self-assembly for drug delivery","volume":"12","author":"Sun","year":"2024","journal-title":"Biomater Sci"},{"key":"10.1016\/j.apsb.2026.06.044_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202403388","article-title":"Natural products from herbal medicine self-assemble into advanced bioactive materials","volume":"11","author":"Guo","year":"2024","journal-title":"Adv Sci"},{"key":"10.1016\/j.apsb.2026.06.044_bib36","article-title":"Accessible and effective nanomedicines: self-assembly products from Chinese herbal medicines","volume":"35","author":"Wang","year":"2025","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.apsb.2026.06.044_bib37","first-page":"220","article-title":"Carrier-free nanodrugs with efficient drug delivery and release for cancer therapy: from intrinsic physicochemical properties to external modification","volume":"8","author":"Mei","year":"2021","journal-title":"Bioact Mater"},{"key":"10.1016\/j.apsb.2026.06.044_bib38","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1021\/acsami.1c16737","article-title":"Natural small molecules enabled efficient immunotherapy through supramolecular self-assembly in P53-mutated colorectal cancer","volume":"14","author":"Ji","year":"2022","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apsb.2026.06.044_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202405781","article-title":"Intranasal delivery of pure nanodrug loaded liposomes for Alzheimer's disease treatment by efficiently regulating microglial polarization","volume":"20","author":"Feng","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.apsb.2026.06.044_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202370052","article-title":"Inherent capability of self-assembling nanostructures in specific proteasome activation for cancer cell pyroptosis","volume":"19","author":"Luo","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.apsb.2026.06.044_bib41","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s41565-021-00962-9","article-title":"Amplifying STING activation by cyclic dinucleotide-manganese particles for local and systemic cancer metalloimmunotherapy","volume":"16","author":"Sun","year":"2021","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2026.06.044_bib42","doi-asserted-by":"crossref","first-page":"10439","DOI":"10.1021\/acsnano.3c11374","article-title":"Self-assembled STING-activating coordination nanoparticles for cancer immunotherapy and vaccine applications","volume":"18","author":"Sun","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2026.06.044_bib43","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s41565-022-01225-x","article-title":"Zinc cyclic di-AMP nanoparticles target and suppress tumours via endothelial STING activation and tumour-associated macrophage reinvigoration","volume":"17","author":"Yang","year":"2022","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2026.06.044_bib44","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1002\/cmdc.201800481","article-title":"Identification of \u03b1-mangostin as a potent agonist of human STING","volume":"13","author":"Zhang","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.apsb.2026.06.044_bib45","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2026.06.044_bib46","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/s41565-021-00950-z","article-title":"Immunogenic camptothesome nanovesicles comprising sphingomyelin-derived camptothecin bilayers for safe and synergistic cancer immunochemotherapy","volume":"16","author":"Wang","year":"2021","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2026.06.044_bib47","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41568-021-00347-z","article-title":"Systemic immunity in cancer","volume":"21","author":"Hiam-Galvez","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2026.06.044_bib48","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.immuni.2019.12.010","article-title":"Human anti-tumor immunity: insights from immunotherapy clinical trials","volume":"52","author":"Egen","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2026.06.044_bib49","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and hot tumors: from molecular mechanisms to targeted therapy","volume":"9","author":"Wu","year":"2024","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.apsb.2026.06.044_bib50","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.2535","article-title":"Estimation of the percentage of US patients with cancer who are eligible for and respond to checkpoint inhibitor immunotherapy drugs","volume":"2","author":"Haslam","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.apsb.2026.06.044_bib51","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nri3875","article-title":"Translating nucleic acid-sensing pathways into therapies","volume":"15","author":"Junt","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2026.06.044_bib52","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrc.2016.14","article-title":"Antitumour actions of interferons: implications for cancer therapy","volume":"16","author":"Parker","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2026.06.044_bib53","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41573-018-0011-2","article-title":"Interferons \u03b1 and \u03b2 in cancer: therapeutic opportunities from new insights","volume":"18","author":"Borden","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2026.06.044_bib54","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-cancerbio-030518-055636","article-title":"Roles of the cGAS-STING pathway in cancer immunosurveillance and immunotherapy","volume":"3","author":"Yum","year":"2019","journal-title":"Ann Rev Cancer Biol"},{"key":"10.1016\/j.apsb.2026.06.044_bib55","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors","volume":"41","author":"Woo","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2026.06.044_bib56","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41586-018-0705-y","article-title":"Design of amidobenzimidazole STING receptor agonists with systemic activity","volume":"564","author":"Ramanjulu","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.06.044_bib57","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1126\/science.aba6098","article-title":"An orally available non-nucleotide STING agonist with anti-tumor activity","volume":"369","author":"Pan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.apsb.2026.06.044_bib58","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1126\/science.abb4255","article-title":"anti-tumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic","volume":"369","author":"Chin","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.apsb.2026.06.044_bib59","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1002\/anie.200902672","article-title":"Poly (ethylene glycol) in drug delivery: pros and cons as well as potential alternatives","volume":"49","author":"Knop","year":"2010","journal-title":"Angew Chem, Int Ed"},{"key":"10.1016\/j.apsb.2026.06.044_bib60","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","article-title":"Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals","volume":"154","author":"Kozma","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2026.06.044_bib61","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations","volume":"1-2","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.apsb.2026.06.044_bib62","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J Comput Chem"},{"key":"10.1016\/j.apsb.2026.06.044_bib63","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jmgm.2005.12.005","article-title":"Automatic atom type and bond type perception in molecular mechanical calculations","volume":"25","author":"Wang","year":"2006","journal-title":"J Mol Graph Model"},{"key":"10.1016\/j.apsb.2026.06.044_bib64","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/jcc.540161106","article-title":"Application of the multimolecule and multiconformational RESP methodology to biopolymers - charge derivation for DNA, RNA, and proteins","volume":"16","author":"Cieplak","year":"1995","journal-title":"J Comput Chem"},{"key":"10.1016\/j.apsb.2026.06.044_bib65","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1021\/j100142a004","article-title":"A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges\u2012the resp model","volume":"97","author":"Bayly","year":"1993","journal-title":"J Phys Chem"},{"key":"10.1016\/j.apsb.2026.06.044_bib66","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J Mol Graph"},{"key":"10.1016\/j.apsb.2026.06.044_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101664","article-title":"Protocol to isolate and analyze mouse bone marrow derived dendritic cells (BMDC)","volume":"3","author":"Sauter","year":"2022","journal-title":"STAR Protoc"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526004016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526004016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:20:08Z","timestamp":1789600808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383526004016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":67,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2211383526004016"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2026.06.044","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-assembled supramolecular nanoparticles of \u03b1-mangostin for targeted STING activation and enhanced tumor immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2026.06.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}